Ventricular tachycardia

VT is a pulse rate of more than 100 beats per minute originating from either ventricle, with at least 3 abnormal rapid heartbeats in a row.

The condition can develop as an early or late complication of a heart attack. It may also occur in people with:

• Cardiomyopathy
• Heart failure (also called congestive heart failure)
• Heart surgery
• Myocarditis
• Valvular heart disease

VT can occur without other heart disease.

Scar tissue may form in the muscle of the ventricles days, months, or years after a heart attack. This can lead to ventricular tachycardia.

VT can also be caused by:

• Anti-arrhythmic medicines (used to treat an abnormal heart rhythm)
• Changes in blood chemistry (such as a low potassium level)
• Changes in blood pH (acid-base imbalance)
• Lack of enough oxygen

"Torsade de pointes" is a specific form of VT. It is often due to congenital heart disease or the use of certain medicines.

You may have symptoms if the heart rate during a VT episode is very fast or lasts longer than a few seconds. Symptoms may include:

• Chest discomfort (angina)
• Fainting (syncope)
• Lightheadedness or dizziness
• Sensation of feeling the heart beat (palpitations)
• Shortness of breath

Symptoms may start and stop suddenly. In some cases, there are no symptoms.

The health care provider will look for:

• Absent pulse
• Loss of consciousness
• Normal or low blood pressure
• Rapid pulse

Tests that may be used to detect ventricular tachycardia include:

• Electrocardiogram (ECG)
• Holter monitor
• Intracardiac electrophysiology study (EPS)
• Rhythm monitoring with a loop recorder or device

You may also have blood chemistries and other tests.

The treatment depends on the symptoms, and the type of heart disorder.

If someone with VT is in distress, they may require:

• Cardiopulmonary resuscitation (CPR)
• Cardioversion (electric shock)
• Medicines (such as lidocaine, procainamide, sotalol, or amiodarone) given through a vein

After an episode of VT, steps are taken to prevent further episodes.

• Medicines taken by mouth may be needed for long-term treatment. However, these medicines may have severe side effects. They are being used less often as other treatments are developed.
• A procedure to destroy the heart tissue that is causing the abnormal heartbeat (called ablation) may be done.
• An implantable cardioverter defibrillator (ICD) may be recommended. It is an implanted device that detects any life-threatening, rapid heartbeat. This abnormal heartbeat is called an arrhythmia. If it occurs, the ICD quickly sends an electrical shock to the heart to change the rhythm back to normal. This is called defibrillation.

The outcome depends on the heart condition and symptoms.

Ventricular tachycardia may not cause symptoms in some people. However, it can be deadly. It is a major cause of sudden cardiac death.

Go to the emergency room or call 911 or the local emergency number if you have a rapid, irregular pulse, faint, or have chest pain. All of these may be signs of ventricular tachycardia.

In some cases, the disorder cannot be prevented. In other cases, it can be prevented by treating heart problems and avoiding certain medicines.

Wide-complex tachycardia; V tach; Tachycardia - ventricular

Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS Guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2018;72(14):1677-1749. PMID: 29097294 pubmed.ncbi.nlm.nih.gov/29097294/.

Garan H. Ventricular arrhythmias. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 53.

Stevenson WG, Keppenfeld K. Ventricular arrhythmias. In: Bonow RO, Mann DL, Tomaselli GF, et al, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 13th ed. Philadelphia, PA: Elsevier; 2026:chap 49.

Updated by: Thomas S. Metkus, MD, PhD, Associate Professor of Medicine and Surgery, Johns Hopkins University School of Medicine, Baltimore, MD. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.